Delivery Order SPE2DR25D3102-SPE2DR26F2Q4A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,591.00 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location of the awardee. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,923.46 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a completion date of October 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $1,385.22 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count). This competitively awarded, firm fixed-price delivery order was executed on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) under a firm fixed-price contract valued at $3,925.16. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's role...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,031.28 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a firm fixed price structure. This non-set-aside award was competitively procured and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) under a firm fixed price contract valued at $1,390.76. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,781.36 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count packages) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a contract value of $6,104.22. This non-competitive, firm fixed-price delivery order is set to be completed by December 31, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,615.86 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, issued on May 15, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a $1,694.97 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count unit) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2Q4ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,417.46 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This non-competitive, firm fixed-price delivery order was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as the prime contractor on this and numerous other federal contracts supplying prescription medications, medical devices, and specialized healthcare commodities to military treatment facilities and veteran healthcare systems. The company competes on a full and open basis for federal procurements and demonstrates extensive capability in fulfilling government pharmaceutical supply requirements across multiple therapeutic domains. This delivery order exemplifies the routine pharmaceutical procurement operations conducted through DLA's medical supply chain to support military and federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/12/26 |